Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (24 ops.)
Latest filing published 18 Sept 2026 for Progyny, Inc., €268k.
Filing timeline
BuySaleKevin K. Gordon
Insider track record
Disclosed buys
0
Disclosed sells
24
Signal history
Kevin K. Gordon: trading record in brief
The three largest sales by Kevin K. Gordon all date from 2016 and come from Iqvia Holdings Inc., where the declared title is EVP and COO: EUR 1,451,415 on April 12, EUR 1,433,303 on March 1 and EUR 1,408,604 on June 9. They sit within 24 sales worth EUR 9,053,386 in all, with a median of EUR 148,256, and no purchase.
Kevin K. Gordon is filed at four Nasdaq-listed companies: Iqvia (16 filings), Progyny, Inc. (13, Director), Veracyte, Inc. (9, Director) and Liquidia Technologies Inc (6, President and CFO). The 44 filings run from March 2, 2016 to September 18, 2026 and also include 16 share grants and 4 option exercises.
The year 2016 dominates with 16 filings; there is only one in 2018, then 2 to 5 a year. Four filings, two of them sales, fall in the last twelve months. The publication delay is 2 days at the median.
The count of trades by Gordon within 30 days of colleagues is 3, 3 and 2. All on the same side. In the same order, the colleagues are 3I Corp (Iqvia Holdings Inc.), Benjamin Maynor (Liquidia Technologies Inc) and Bonnie H. Anderson (Veracyte, Inc.).
Companies and markets linked to Kevin K. Gordon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations44 total
11,500 shares@ US$27.11810.015% mcap18.7% of flowCommon StockSEC:0001551306-26-000154:2
22,000 shares@ US$13.000.013% mcap17.1% of flowCommon StockSEC:0001551306-26-000152:0
10,500 shares@ US$27.240.013% mcap17.1% of flowCommon StockSEC:0001551306-26-000152:1
11,500 shares@ US$27.94420.015% mcap19.3% of flowCommon StockSEC:0001551306-26-000152:2
2,500 shares@ US$22.0353.3% of flowCommon StockSEC:0001551306-25-000169:0
8,026 shares0Common StockSEC:0001551306-25-000122:0
5,147 shares0Common StockSEC:0001551306-24-000124:0
2,500 shares@ US$35.935.8% of flowCommon StockSEC:0001551306-23-000112:0
1,410 shares@ US$38.243.4% of flowCommon StockSEC:0001628280-23-019976:1
3,654 shares0Common StockSEC:0001628280-23-019976:0
2,900 shares0Common StockSEC:0001628280-22-027088:0
15,000 shares@ US$18.5020.1% of flowCommon StockSEC:0001384101-22-000080:1
15,000 shares@ US$7.39100.0% of flowCommon StockSEC:0001384101-22-000080:0
2,210 shares0Common StockSEC:0001179110-21-009633:0
8,720 shares0Common StockSEC:0001384101-21-000113:0
10,000 shares@ US$7.395.9% of flowCommon StockSEC:0001437749-21-000133:0
4,477 shares@ US$48.6217.3% of flowCommon StockSEC:0001437749-21-000133:1
5,523 shares@ US$49.2721.6% of flowCommon StockSEC:0001437749-21-000133:2
10,000 shares@ US$7.3911.1% of flowCommon StockSEC:0001437749-20-023860:0
8,194 shares@ US$46.951757.7% of flowCommon StockSEC:0001437749-20-023860:1
1,806 shares@ US$47.84913.0% of flowCommon StockSEC:0001437749-20-023860:2
5,000 shares0Common StockSEC:0001209191-20-055955:0
438 shares@ US$18.094.4% of flowCommon StockSEC:0001104659-19-010159:2
293 shares@ US$15.832.6% of flowCommon StockSEC:0001104659-19-010159:0
212 shares@ US$16.832.0% of flowCommon StockSEC:0001104659-19-010159:1
25 of 44 declarations
